Vanesa Bernal Monterde

661 total citations
48 papers, 306 citations indexed

About

Vanesa Bernal Monterde is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Vanesa Bernal Monterde has authored 48 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 18 papers in Hepatology and 15 papers in Physiology. Recurrent topics in Vanesa Bernal Monterde's work include Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (15 papers) and Nutrition and Health in Aging (7 papers). Vanesa Bernal Monterde is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (15 papers) and Nutrition and Health in Aging (7 papers). Vanesa Bernal Monterde collaborates with scholars based in Spain, France and Sweden. Vanesa Bernal Monterde's co-authors include José M. Arbones-Mainar, Diego Casas Deza, Alejandro Sanz‐París, Miguel Ángel Simón, Isaac Pascual, Trinidad Serrano, Raquel del Moral, Francisco A. García‐Gil, Yolanda González and Silvia Lorente‐Cebrián and has published in prestigious journals such as Gastroenterology, PLoS ONE and The FASEB Journal.

In The Last Decade

Vanesa Bernal Monterde

40 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanesa Bernal Monterde Spain 11 125 120 83 72 37 48 306
Gholamreza Hemmasi Iran 11 224 1.8× 98 0.8× 28 0.3× 87 1.2× 69 1.9× 21 439
Abhinav Anand India 11 215 1.7× 153 1.3× 64 0.8× 127 1.8× 10 0.3× 48 380
Seiji Nakanishi Japan 8 184 1.5× 141 1.2× 53 0.6× 62 0.9× 21 0.6× 19 344
Nicola Napoli Italy 12 174 1.4× 139 1.2× 53 0.6× 68 0.9× 41 1.1× 34 386
Truls Sanengen Norway 11 97 0.8× 112 0.9× 66 0.8× 146 2.0× 60 1.6× 26 391
Tudor Cuciureanu Romania 10 258 2.1× 153 1.3× 32 0.4× 53 0.7× 13 0.4× 52 361
Laura Huiban Romania 10 266 2.1× 178 1.5× 32 0.4× 44 0.6× 13 0.4× 50 370
Elżbieta Woźniak-Grygiel Poland 9 208 1.7× 41 0.3× 53 0.6× 64 0.9× 20 0.5× 25 329
Prateek Lohia United States 9 100 0.8× 27 0.2× 39 0.5× 49 0.7× 62 1.7× 26 311
Konstantinos Mantzoukis United Kingdom 8 261 2.1× 303 2.5× 175 2.1× 91 1.3× 20 0.5× 12 478

Countries citing papers authored by Vanesa Bernal Monterde

Since Specialization
Citations

This map shows the geographic impact of Vanesa Bernal Monterde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanesa Bernal Monterde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanesa Bernal Monterde more than expected).

Fields of papers citing papers by Vanesa Bernal Monterde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanesa Bernal Monterde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanesa Bernal Monterde. The network helps show where Vanesa Bernal Monterde may publish in the future.

Co-authorship network of co-authors of Vanesa Bernal Monterde

This figure shows the co-authorship network connecting the top 25 collaborators of Vanesa Bernal Monterde. A scholar is included among the top collaborators of Vanesa Bernal Monterde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanesa Bernal Monterde. Vanesa Bernal Monterde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deza, Diego Casas, et al.. (2024). Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens. 13(4). 278–278. 3 indexed citations
3.
Deza, Diego Casas, et al.. (2024). MASLD-Related Hepatocarcinoma: Special Features and Challenges. Journal of Clinical Medicine. 13(16). 4657–4657. 3 indexed citations
4.
Barreira‐Díaz, Ana, Mar Riveiro‐Barciela, Vanesa Bernal Monterde, et al.. (2024). Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study. Annals of Hepatology. 29(3). 101489–101489. 3 indexed citations
5.
6.
Segura-Medina, Patricia, et al.. (2023). Percutaneous left atrial appendage closure in patients with gastrointestinal bleeding associated with oral anticoagulants. Scandinavian Journal of Gastroenterology. 58(12). 1547–1554.
7.
Deza, Diego Casas, Ana Martínez-Sapiña, Raquel del Moral, et al.. (2023). Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals. Atherosclerosis. 375. 59–66. 6 indexed citations
8.
Deza, Diego Casas, et al.. (2023). Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases. Nutrients. 15(15). 3487–3487. 6 indexed citations
9.
González, Yolanda, Raquel del Moral, Pilar Calmarza, et al.. (2023). Isthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity. Cardiovascular Diabetology. 22(1). 335–335. 6 indexed citations
10.
Sanz‐París, Alejandro, Yolanda González, Patricia Pérez‐Matute, et al.. (2022). Randomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients. Nutrients. 14(11). 2344–2344. 16 indexed citations
11.
Arbones-Mainar, José M., et al.. (2021). Gastrointestinal and liver immune-related adverse effects induced by immune checkpoint inhibitors: A descriptive observational study. Gastroenterología y Hepatología (English Edition). 44(4). 261–268. 7 indexed citations
12.
Arbones-Mainar, José M., et al.. (2021). Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project. European Journal of Clinical Pharmacology. 77(12). 1927–1933. 9 indexed citations
13.
Monterde, Vanesa Bernal, et al.. (2020). SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines. 8(9). 328–328. 26 indexed citations
14.
Deza, Diego Casas, et al.. (2020). Fallo hepático fulminante en paciente en tratamiento con sunitinib por tumor del estroma gastrointestinal metastásico. Gastroenterología y Hepatología. 44(6). 424–425. 1 indexed citations
15.
Deza, Diego Casas, et al.. (2018). Obstrucción biliar secundaria a seudoaneurisma de la arteria gastroduodenal. Una inusual forma de presentación. Gastroenterología y Hepatología. 42(6). 384–386. 1 indexed citations
16.
Monterde, Vanesa Bernal, et al.. (2018). Citomegalovirus asociado a úlcera gástrica: caso clínico y revisión de la literatura. Gastroenterología y Hepatología. 42(4). 256–258.
17.
Monterde, Vanesa Bernal, Isaac Pascual, Ángel Lanas, et al.. (2011). Cardiac function and aminoterminal pro‐brain natriuretic peptide levels in liver‐transplanted cirrhotic patients. Clinical Transplantation. 26(1). 111–116. 12 indexed citations
18.
Monterde, Vanesa Bernal, Isaac Pascual, Elena Piazuelo, et al.. (2011). Cystatin C Level as a Predictor of Death and Cardiovascular Events After Liver Transplantation. Transplantation Proceedings. 43(3). 732–734. 6 indexed citations
19.
Monterde, Vanesa Bernal, et al.. (2009). 446 CYSTATIN C CONCENTRATION AS A PREDICTOR OF DEATH AND CARDIOVASCULAR EVENTS AFTER LIVER TRANSPLANTATION. Journal of Hepatology. 50. S169–S169. 1 indexed citations
20.
Monterde, Vanesa Bernal, et al.. (2008). Fallo hepático fulminante: indicaciones de trasplante y resultados. Gastroenterología y Hepatología. 31. 46–50.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gholamreza Hemmasi Breakdown of academic impact, for papers by Abhinav Anand Breakdown of academic impact, for papers by Seiji Nakanishi Breakdown of academic impact, for papers by Nicola Napoli Breakdown of academic impact, for papers by Truls Sanengen Breakdown of academic impact, for papers by Tudor Cuciureanu Breakdown of academic impact, for papers by Laura Huiban Breakdown of academic impact, for papers by Elżbieta Woźniak-Grygiel Breakdown of academic impact, for papers by Prateek Lohia Breakdown of academic impact, for papers by Konstantinos Mantzoukis
Rankless by CCL
2026